Clinical Trials Update: Sept. 26 2007
The News Review:
- Clinical Trials Update: Sept. 26 2007
- New Drug Seeks to ‘verload’ Skin Cancer Cells with xygen
- BCM receives $30M gift for breast cancer research
- Stocks to Watch: KB Home Rite Aid
- Vet research gets $29m boost to fight new diseases
- Bloomberg.com: Health Care
Clinical Trials Update: Sept. 26 2007
ABC News – Sep 26, 2007
Qualified participants will receive the study medication study-related medical care and may receive compensation for time and travel. The research site is in Birmingham Ala. More informationPlease see.
New Drug Seeks to ‘verload’ Skin Cancer Cells with xygen
FXNews – Sep 26, 2007
Unlike regular cells which naturally cannot have their oxidant levels raised beyond a certain threshold cancer cells cannot balance the amount of free radicals inside them. With the new drug STA-4783 doctors may be able to overload the cancer cells with oxygen-containing chemicals to the point where the cells cannot cope and simply die off according to research presented Wednesday at a meeting of the European Cancer rganization in Barcelona. “We are taking advantage of the Achilles heel of cancer cells” said Dr. Anthony Williams vice president of clinical research at Synta Pharmaceuticals Corp. based in Lexington Massachusetts which paid for the study. STA-4783 which has no effect on normal cells is the first of several such drugs planned for study though no other companies have yet to release results from their research. It could also be used against other cancers such as pancreatic or ovarian as they have been shown to naturally contain higher levels of oxygen.
BCM receives $30M gift for breast cancer research
Bizjournals.com – Sep 26, 2007
5 million to the college's Human Genome Sequencing Center and $5 million for public education and community outreach. The college has committed to raise an additional $30 million to match the gift from The Smith Foundation. The gift will help fund breast screening and diagnostic equipment construction of the new breast center at the McNair Campus of BCM molecular genetic and clinical research and the recruitment of faculty and staff. "This is where the cures for tomorrow are going to come from" said Lester Smith. "What we are going to see here is the opportunity to deliver highly personalized care to patients. There is a true collaboration between these two departments and that will lead to new discoveries not only in breast cancer but other deadly diseases as well. " "This collaboration between the breast cancer and genomic programs represents the type of science-based patient-oriented initiative that will lead the way in changing how medicine is practiced in the future" said BCM President and Chief Executive fficer Dr.
Stocks to Watch: KB Home Rite Aid
FXNews – Sep 26, 2007
The third installment of Microsoft’s Halo title is seen as a key to reaching profitability for the company’s entertainment & devices unit this fiscal year. Parexel International Corp. (PRXL) said it completed its purchase of Taiwan-based Apex International Clinical Research Co. and restated its forecast to reflect the deal. The biopharmaceutical services company now anticipates consolidated service revenue of $203 to $210 million for the first quarter and consolidated service revenue of $875 to $910 million for fiscal 2008. Paraxel previously forecast revenue of $200 to $210 million for the first quarter and $855 to $885 million for the year.
Vet research gets $29m boost to fight new diseases
Horsetalk – Sep 26, 2007
“I am delighted that the Wellcome Trust is working in partnership with the UK veterinary colleges to strengthen veterinary research an area of increasing importance” says Lord Selborne. “This initiative will build on the Trust’s ongoing support of this field and on the Veterinary Training Research Initiative established in response to the report that I chaired which identified the lack of training opportunities for veterinary researchers. The programme will deliver 20 Clinical Research Training Fellows each with a PhD and a clinical or pathology specialist qualification as well as number of postdoctoral fellows and clinical doctoral fellows each with a DVM and specialist postgraduate training in laboratory animal medicine. In addition leading to these centrepiece awards will be 175 Vacation Scholarships 175 Intercalation Awards support for 5 Summer Schools and 9 one-year Research Entry Scholarships. To coincide with the announcement of the new programme the Royal College of Veterinary Surgeons (RCVS) has launched The Impact of Veterinary Research a brochure to promote the key role that veterinary research plays in our lives. “I have spent over 40 years in practice and have seen the array of medicines and techniques available to the veterinary surgeon increase exponentially over the years” says Dr Bob Moore RCVS President. “I am very much aware of the enormous importance of veterinary research not only to the veterinary profession but to the world at large.
Bloomberg.com: Health Care
Bloomberg – Sep 26, 2007
They also worried that therelative ease of patient recruitment in Russia was a sign offraud. An FDA inspection found no such evidence Laughren said. The Russian studies “meet or exceed internationallyaccepted principles of clinical research'' Lilly's Puls said. Almost 44 percent of teenagers taking Zyprexa gained morethan 7 percent of their body weight compared with 7 percent ofthose on placebos according to Laughren. Levels of fats bloodsugar and the hormone.
Written by admin on September 26th, 2007 with
no comments.
Read more articles on News.